generics

Europe revokes marketing authorization for generic versions of Biogen's MS drug
Reuters
Tue, 12/19/23 - 10:08 am
Biogen
Tecfidera
MS
multiple sclerosis
Europe
generics
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
Tue, 10/3/23 - 07:35 pm
patents
Novo Nordisk
generics
Wegovy
Ozempic
Generics maker VistaPharm recalls ulcer med on bacteria contamination fears
Fierce Pharma
Mon, 09/25/23 - 11:39 am
VistaPharm
product recalls
generics
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Thu, 09/21/23 - 11:51 am
Takeda
generics
gout
Colcrys
antitrust
The fading generics industry and essential medicine supply
Pharmaphorum
Tue, 09/19/23 - 10:31 am
generics
supply chain
drug shortages
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
Wed, 09/6/23 - 10:12 am
JNJ
tuberculosis
generics
bedaquiline
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Teva to Pay $225M in DOJ Generic Drug Price-Fixing Settlement
BioSpace
Tue, 08/22/23 - 10:15 am
Teva Pharmaceutical
DOJ
price fixing
legal
generics
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Novartis
Sandoz
spinoff
biosimilars
generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Mon, 08/14/23 - 06:47 pm
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Bristol Myers Squibb
Eliquis
generics
In win for generics industry, Viatris wards off $50M payment in tax battle with IRS
Fierce Pharma
Mon, 07/31/23 - 10:06 pm
Viatris
IRS
taxes
patents
generics
Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims
Fierce Pharma
Wed, 07/5/23 - 07:17 pm
Gilead Sciences
Teva Pharmaceutical
HIV
pay-for-delay
generics
legal
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Fri, 06/30/23 - 10:16 am
Sanofi
Jevtana
generics
Sandoz
prostate cancer
legal
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
Wed, 06/21/23 - 11:51 am
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Novartis
Sandoz
generics
biosimilars
US Military Is So Worried About Drug Safety It Wants to Test Widely Used Medicines
Bloomberg
Thu, 06/8/23 - 09:53 am
Valisure
generics
Department of Defense

Pages